Background. Integrated cancer care requires cooperation between specialists and general practitioners (GPs). Mutual understanding of each other's tasks and responsibilities is essential if cooperation is to be successful. While GPs' opinions about oncologists have been addressed in previous studies, less is known about oncologists' views on the role of GPs' in cancer care, especially with regard to GPs' patient-centred, communication-based tasks. Objective. To assess oncologists' views on the importance of GPs for cancer patients. Methods. We conducted 15 qualitative guideline-based telephone interviews with oncologists using open-ended questions and analysed these interviews using thematic analysis. Results. Oncologists situated GPs as persons of trust for patients in a rather amicable sphere of caring in contrast to themselves who were situated in a rather biomedical sphere of evidencebased treatment decisions. Oncologists' appraisal of an overlapping of these spheres varied: While most stressed opportunities for patients (and themselves), others also mentioned risks. Conclusion. Our analysis found that oncologists clearly distinguish between their own sphere of evidence-based treatment decision-making and GPs' sphere of psychosocial caring. The question remains how these roles get interconnected in real life situations in order to meet patients' needs adequately. So far it seems that it is often the patient who is travelling between both spheres and needs to initiate interconnection to get comprehensive cancer care.
Introduction
Cancer care is a multiprofessional field, in which oncologists, radiologists, surgeons, site-specific specialists such as gynecologists and urologists, and general practitioners (GPs) all play a role. GPs' tasks in cancer care range from prevention, cancer screening and diagnosis, blood withdrawal and the treatment of side-effects during therapy, shared follow-up and survivorship care, to end-of-life care (1) . To ensure continuity of cancer care and the best possible treatment for patients, cooperation between cancer specialists and GPs is necessary (2, 3) . Some characteristics have been identified to ensure such effective cooperation in healthcare including having a shared model of care that takes others' contributions into account as well as clarity of roles (3, 4) .
However, GPs and oncologists often differ in their perceptions of the role of the GP in cancer care. In a survey of 3596 GPs and oncologists in the USA, 59% and 75% of GPs respectively agreed or strongly agreed that GPs were able to provide follow up care and detect recurrence, compared to only 23% and 38% of oncologists (5) . In another US survey involving 255 GPs and 123 oncologists, 57% of GPs said follow-up care was mainly or fully the responsibility of GPs and 30% reckoned that both GPs and oncologists should fulfil this role, compared to zero and 2% of oncologists, respectively (6) . A Canadian survey involving 232 GPs, 45 cancer specialists and 395 cancer patients found that a significantly higher proportion of GPs and patients expect GPs to participate in the coordination of care and communication of information during diagnosis and treatment than oncologists. Nevertheless, in the advanced and terminal stages, a high proportion of all three groups expected GPs' involvement. Among all groups, more than 80% of participants said they expected GPs to provide emotional support in all stages of care (7) . A qualitative study among surgical oncologists, dermatologists and melanoma unit GPs on shared cancer follow-up care found that the main responsibility for follow-up care was located at the specialists' site. However, local GPs were considered important especially for anxious patients as an additional person to contact that provides reassurance and addresses patients' psychosocial needs (8) . Another qualitative study from Canada that asked oncologists on their perspective on GPs' role in follow-up care reported that oncologists valued GPs' knowledge on cancer patients and their families and wished stronger collaboration with GPs to exceed the 'black box' of cancer centres. Simultaneously, oncologists felt that GPs might misgauge their ability to deal with oncological emergencies and might influence patients negatively with regard to chemotherapy (9) .
Studies on patients' perspectives on GPs' involvement in cancer care emphasize the importance of GPs' patient-centred, communication-based tasks. In some studies, patients rated their GP's ability to manage medical problems relating to tumour treatment as low (10) (11) (12) . However, even in these studies, cancer patients reported that their GP was involved in their cancer care and that this involvement was important to them (10) (11) (12) (13) (14) . Cancer patients consult their GPs on treatment decisions, and particularly the decision to terminate treatment (11, 12, 15) . They also arrange appointments with their GP to review consultations with their oncologist (16) . Patients value their GP because they can ask him or her different questions on cancer than their oncologist (12) and they feel considered as a 'whole person' (12, 17) . GPs provide reassurance and emotional support (11, 14, 16, 18, 19) and diminish fears of being alone with the disease (14) .
This brief overview of the literature shows that studies on patient perspectives stress GPs' importance for cancer patients with regard to patients feeling supported, while tasks addressing patients' psychosocial needs are rarely addressed in surveys on oncologists' views. Some qualitative studies deal with oncologists' perspective on GPs' involvement in cancer care and show that oncologists have mixed feelings.
To comprehend specialist-GP cooperation it is important to gain a deeper understanding of oncologists' views on GPs' importance for cancer patients and to understand how they relate this role to their own responsibilities. To investigate these questions, we conducted a qualitative interview study that addressed oncologists' views on the importance of GPs in the care of cancer patients.
Methods

Study design and data collection
In February 2016, we contacted oncologists working in an outpatient setting by email and invited them to participate in a qualitative interview study on their views concerning the role of GPs in cancer care. Recruitment was supported by WINHO, the Scientific Institute of Office-Based Hematologists and Oncologists in Germany. IK and JE conducted 15 telephone interviews averaging 30 minutes in length. Interviews were audio-taped. We used an interview guideline with open-ended questions on the tasks carried out by GPs, on how sensible oncologists view the work done by GPs, on communication between the two groups, and the importance of GPs to cancer patients (see appendix).
Analysis
Interview data was transcribed, anonymized, and entered into MAXQDA 11. In a first step, the data was analysed inductively by CG, IK and JE using thematic analysis (20) with a general focus on oncologists' views of the role of GPs in cancer care. A coding system encompassing 54 codes was developed by comparing and discussing individually developed codes and coded segments. This general coding system included, for example, codes on general medical tasks performed by GPs such as taking blood etc., on GPs as an information resource for oncologists and on the importance of GPs to patients. The concept of 'the GP as a person of trust' was a particularly prominent concept that was shared by all our interviewees, but the meaning seemed to be very diverse. Therefore, in a second step, codes relating to GPs' importance to patients such as 'the GP as a person of trust' and codes that overlapped with this code such as 'support in decision-making', 'discussing therapies' or 'prognosis' were analysed inductively by CG and JE and interpretations were discussed with CH. This paper is based on a detailed in-depth analysis (20) of the codes that concerned the importance of GPs to patients.
Results
Sample
Our sample consisted of three female and 12 male medical oncologists, all of whom worked in group practices in outpatient settings in different parts of Germany. Median age was 58 and ranged from 35 to 62. Median work experience was 22.5 years, ranging from 1 to 30 years. Eight interviewees reported having additional training in palliative care, two reported additional training in psycho-oncology or psychotherapy and two in infectiology.
The GP as a person of trust
The concept of 'the GP as a person of trust' (in German 'Vertrauensperson') was introduced by oncologists. It was a phrase that interviewees came up with in various contexts, such as patient-GP conversations, GPs' overall responsibilities in cancer care, general assumptions about what happens at the GP's office and discussions between oncologists and GPs. This role was often described as a complement to oncologists' role as specialists. The idea that the GP is a person of trust was based upon their knowledge of the medical history and family situation of their patients, as well as the duration of their relationships with patients: ' The GP is generally a person of trust for our patients, because the doctor-patient relationship has generally existed for many years, whereas we only met the patient once the cancer developed. That makes for a clear difference in the doctor-patient relationship' (oncologist_N).
'We are the specialists and we're responsible for therapy decisions. We are the primary contact person for the cancer therapy.
And from the point of view of the patients, the GP is not the specialist and patients can't ask him specific questions, but is rather a bit like a … perhaps a person of trust' (oncologists_B).
'Perhaps the patient discusses personal life planning and such things a bit; things that aren't so important when you're here and undergoing chemotherapy. The patient speaks to us more about the acute problems concerning the chemotherapy and planning the chemotherapy and carrying it out; with the GP it's the deeper problems because he has a different relationship to the GP than to us. That's why we complement each other pretty well' (oncologists_F).
Oncologists assumed that GPs talked with patients in a different way than oncologists did. In the interviews, oncologists situated the GP in a rather amicable sphere of caring and life coaching in contrast to their own sphere of evidence-based treatment decisions. This contrast in doing and talking formed the overarching theme of the GP as person of trust in the interviews.
Opportunities and risks of GPs' role as persons of trust
Oncologists connected GPs' role as persons of trust with several opportunities but also with risks. Opportunities mentioned by oncologists included GPs' ability to deal with anxious patients, to explain oncologists' treatment decisions to patients and to support this decision, to provide information for oncologists' treatment decisions or treatment termination. Risks included GPs providing information that is not up-to-date and GPs endangering the patient-oncologist relationship by challenging oncologists' treatment decisions.
Opportunities connected to GPs' role as persons of trust
GPs' role as persons of trust allows GPs to deal with anxious patients and psychosocial problems and to explain to patients what was said during oncologists' consultations:
'The GP is important for patients that are anxious and distrustful and that have had a long-standing association with them and that want to discuss everything a second time. And then the GP rings up here: "Could you just explain it to me; the patient didn't understand it. I want to explain it to him again". Another group of patients are those that have complications or problems during the therapy, and that need to talk about them, both from a general medical point of view, as well as from a psychological point of view; about psychological problems that the patient has at times, that he doesn't want to do it anymore because he's afraid of the side effects' (oncologist_O).
Another opportunity of GPs' role as persons of trust was seen in their ability to support and mediate oncologists' treatment decisions: ' Of course, we tell the GP what we would recommend so he knows what we think. And when both of us say the same thing, it's obviously much easier for the patient to accept. I think the GP is very important for the patient. He's obviously going to ask him. And when the GP says: "Well the tumor is serious and Doctor X, well he is the specialist, if he recommends to you to do that then it is a good thing. You should consider doing it", then the patient is reassured' (oncologist_L).
Due to their knowledge of patients' overall constitution and family situation, GPs as persons of trust can help oncologists in reaching treatment decisions, especially on the termination of treatment: ' As the GP has known the patient for much longer, he is a better judge of what he can deal with and what is possible, given the situation at home. We need a team at home for many of the therapies we carry out. They may need help from friends, spouse, family support. And that is sometimes difficult for us to judge when you've only known the patient for an hour. That's something that the GP can often help us a lot with. And so it's good for us to agree on things. Also, for example, when you're going to end the therapy' (oncologist_D).
While most interviewees discussed GPs' role as persons of trust in relation to the oncologists' treatment decision, the following oncologist described the patient as an active decision-maker and the GP as an acceptable co-counsellor in this decision-making: ' Many different roads lead to Rome. Therefore all we have to do is to discuss things and explain why we are doing something in such a way, or why we wouldn't recommend doing something. If the patient or GP don't agree -that's fine! The important thing is that it's been discussed. The patient has to choose the road himself. At the end of the day, he's the one that selects the therapy' (oncologist_M).
In the situations depicted here the intersection of the amicable sphere of the GP and the biomedical sphere of the oncologists is seen as beneficial both for patients and for cancer care provided by oncologists.
Risks connected to GPs' role as persons of trust
A major risk was seen in GPs' provision of out-of-date information and in challenging oncologist-patient relationships by contesting oncologists' treatment decisions:
'When a relationship of trust to the GP exists, then he will be asked, and that can make communication difficult. If the GP is not up to date with new developments or has had bad experiences or is critical of tumor therapies then it can cause problems for the doctor-patient relationship, as well as for the oncologist-GP relationship' (oncologist_H).
In these segments the intersection of the GPs' amicable sphere of caring and oncologists' biomedical sphere of evidence-based treatment decisions is seen as rather dysfunctional.
However, another assumption on the relation of the GPs' and the oncologists' sphere was that both patients and GPs strictly separate these spheres and therefore no risks due to potential overlapping exist: ' Patients do talk about it when they come to us … I often even ask: "What does your GP think?" Because I know he is a person they trust. And then the patients say this to me. Either the GP says: "You'll have to discuss the details with the oncologist." Or he says: "I can't comment on that." It all depends. But it doesn't happen very often that we have the impression that GPs -in a negative sense -interfere with the therapy or with patient management' (oncologist_A).
Discussion
Main findings
Oncologists situated GPs as persons of trust in a rather amicable sphere of caring in contrast to oncologists who are situated in a rather biomedical sphere of evidence-based treatment decisions. Oncologists' appraisal of an overlapping of these spheres varied: While most stressed opportunities for patients (and themselves), others also mentioned risks.
Relation to existing literature
Our qualitative interview study adds to surveys on oncologists' perspectives on GPs' roles in cancer care (5-7) by not only focusing on GPs' tasks in the provision of medical services, but also explicitly addressing GPs' significance for cancer patients as seen by oncologists. This significance and GPs' communication tasks, which were identified as being of importance for cancer patients in previous studies (11, 12, (14) (15) (16) (17) (18) (19) , were reflected in the interviewed oncologists' considerations of GPs' role in cancer care. The high presence of the concept of 'the GP as a person of trust' in interviews points to oncologists' awareness of cancer patients' needs to address fears, getting reassured and to talk about their disease apart from tumour treatment (11, 12, 14, (16) (17) (18) (19) , even though addressing these needs is not seen as part of oncologists' responsibility by most interviewees. Consistent with previous surveys, the interviewed oncologists in our study felt responsible for all cancer treatment-related tasks (5-7) including decision-making while the GP as a person of trust was seen as a counterpart taking over tasks such as life-coaching and 'talking differently'. Oncologists discussed positive and negative effects of an overlapping of GPs' sphere of caring and oncologists' sphere of evidence-based treatment decisions.
Perceived opportunities of GPs' role as persons of trust such as informing about oncologists' treatment decisions, explaining oncologists' treatment decisions to patients and supporting these decisions relate to the GP as a supportive source not only for patients but also for oncologists. Not only do patients seem to wish the GP to act as an advocate (12), but also some oncologists regard GPs as a link and mediator between specialist and patient.
Oncologists' perceived risks of GPs' role as persons of trust such as confusing patients by providing outdated information and therefore endangering oncologist-patient-relationships may point to GPs' additional training needs in regard to cancer treatment and prognosis. However, this may also point to GPs' need for additional information transfer from specialists with regard to cancer diagnosis, prognosis and treatment of their patients (21, 22) . Different from some interviewees understanding, these topics are obviously addressed by patients in GP consultations (11, 12, 15, 16) . Therefore, the timely provision of information by oncologists to inform these conversations and to prevent misinformation by GPs is beneficial.
Implications for Practice
Perceived opportunities may foster while perceived risks may hinder oncologists in cooperating with GPs. However, two points must be stressed in regard to the connection of our findings to actual specialist-GP cooperation. First, discussions of GPs' role as persons of trust are clearly located in the context of decision making and GP-patient conversations on cancer treatment, diagnosis and prognosis. Oncologists' views on GPs' involvement in other parts of cancer care such as transmission of information on co-morbidities, medical history and medication at the point of referral to oncologists were not part of the analysis presented in this paper. Second, oncologists were not split into one group focusing on risks and another group focusing on opportunities. Rather during conversations most oncologists mentioned opportunities while some also reflected about risks. Oncologists' considerations on GPs' role as persons of trust therefore need not necessarily lead to a certain behaviour. We believe these reflections should rather be interpreted as mindsets or frames which oncologists use to situationally interpret encounters with patients and GPs. This mindset indicates a clear role understanding for GPs and specialists with situations of overlapping that open up opportunities and necessities of working together. Strengthening physicians' awareness of these moments seems beneficial with regard to patient-centred care. At the end of the day it is the same patient who is treated and who combines psychosocial and biomedical parts of cancer care in one person, even if physicians' roles are clearly separated and perceived as independent from each other. Therefore, we hope that in future discussions of specialists' and GPs' roles in cancer care, these opportunities of overlapping are highlighted and valued so that both patients and specialists can benefit from GPs' role as persons of trust and GPs are supported to fulfil this role in the best possible manner.
Strengths and limitations
Our qualitative interview study supplements surveys on oncologists' perspectives on GPs' role in health care delivery by focusing on aspects of patient-centred care. In this paper, we only presented a specific aspect of our data. However, the codes selected from our general coding system were analysed thoroughly and in depth. During all steps of analysis, we used an inductive approach to data analysis and coded segments, codes and finally interpretations were discussed by four researchers (JE, CG, IK and CH). Recruitment was supported by WINHO, the Scientific Institute of Office-Based Hematologists and Oncologists. Therefore, oncologists with a general interest in health care research and the topic of GPs' role in cancer care might be overrepresented.
Conclusion
Our analysis found that oncologists clearly distinguish between their own sphere of evidence-based treatment and decision-making and GPs' sphere of psychosocial caring. The question remains how these roles get interconnected in real life situations in order to meet patients' needs adequately. So far it seems that it is often the patient who is travelling between both spheres and needs to initiate interconnections (3) to get comprehensive cancer care.
